In vivo tumor targeting and image-guided drug delivery with antibody-conjugated, radiolabeled mesoporous silica nanoparticles

ACS Nano

Volumn 7, Issue 10, 2013, Pages 9027-9039

  Chen, Feng ^a   Hong, Hao ^a   Zhang, Yin ^b   Valdovinos, Hector F ^b   Shi, Sixiang ^a   Kwon, Glen S ^a   Theuer, Charles P ^c   Barnhart, Todd E ^b   Cai, Weibo ^a,b,d  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^c TRACON Pharmaceuticals Inc   (United States)

^d UNIVERSITY OF WISCONSIN   (United States)

Author keywords

drug delivery; in vivo tumor targeting; mesoporous silica (mSiO2) nanoparticles; positron emission tomography (PET); theranostics; tumor angiogenesis

Indexed keywords

MESOPOROUS SILICA; POSITRON EMISSION TOMOGRAPHY (PET); THERANOSTICS; TUMOR ANGIOGENESIS; TUMOR TARGETING;

ANTIBODIES; BIOCOMPATIBILITY; DRUG DELIVERY; MAMMALS; MEDICAL IMAGING; NANOPARTICLES; POSITRON EMISSION TOMOGRAPHY; STRUCTURAL DESIGN; SYNTHESIS (CHEMICAL);

TUMORS;

ANTIBODY CONJUGATE; DRUG CARRIER; NANOPARTICLE; SILICON DIOXIDE;

ANIMAL; ARTICLE; CHEMISTRY; INFRARED SPECTROSCOPY; MOUSE; POSITRON EMISSION TOMOGRAPHY; TISSUE DISTRIBUTION; TRANSMISSION ELECTRON MICROSCOPY;

ANIMALS; DRUG CARRIERS; IMMUNOCONJUGATES; MICE; MICROSCOPY, ELECTRON, TRANSMISSION; NANOPARTICLES; POSITRON-EMISSION TOMOGRAPHY; SILICON DIOXIDE; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; TISSUE DISTRIBUTION;

EID: 84886997196     PISSN: 19360851     EISSN: 1936086X     Source Type: Journal    
DOI: 10.1021/nn403617j     Document Type: Article

References (49)

1. Ho, D.; Sun, X.; Sun, S. Monodisperse Magnetic Nanoparticles for Theranostic Applications Acc. Chem. Res. 2011, 44, 875-882
2. Xia, Y.; Li, W.; Cobley, C. M.; Chen, J.; Xia, X.; Zhang, Q.; Yang, M.; Cho, E. C.; Brown, P. K. Gold Nanocages: From Synthesis to Theranostic Applications Acc. Chem. Res. 2011, 44, 914-924
3. Liu, Z.; Liang, X. J. Nano-Carbons as Theranostics Theranostics 2012, 2, 235-237
4. Yang, K.; Feng, L.; Shi, X.; Liu, Z. Nano-Graphene in Biomedicine: Theranostic Applications Chem. Soc. Rev. 2013, 42, 530-547
5. Chen, F.; Bu, W.; Zhang, S.; Liu, X.; Liu, J.; Xing, H.; Xiao, Q.; Zhou, L.; Peng, W.; Wang, L. et al. Positive and Negative Lattice Shielding Effects Co-existing in Gd (III) Ion Doped Bifunctional Upconversion Nanoprobes Adv. Funct. Mater. 2011, 21, 4285-4294
6. Chen, F.; Zhang, S.; Bu, W.; Chen, Y.; Xiao, Q.; Liu, J.; Xing, H.; Zhou, L.; Peng, W.; Shi, J. A Uniform Sub-50 nm-Sized Magnetic/Upconversion Fluorescent Bimodal Imaging Agent Capable of Generating Singlet Oxygen by Using a 980 nm Laser Chemistry 2012, 18, 7082-7090
7. Pan, D. Theranostic Nanomedicine with Functional Nanoarchitecture Mol. Pharmacol. 2013, 10, 781-782
8. Chen, X.; Gambhir, S. S.; Cheon, J. Theranostic Nanomedicine Acc. Chem. Res. 2011, 44, 841-841
9. Lee, J. E.; Lee, N.; Kim, T.; Kim, J.; Hyeon, T. Multifunctional Mesoporous Silica Nanocomposite Nanoparticles for Theranostic Applications Acc. Chem. Res. 2011, 44, 893-902
10. Yang, P.; Gai, S.; Lin, J. Functionalized Mesoporous Silica Materials for Controlled Drug Delivery Chem. Soc. Rev. 2012, 41, 3679-3698
11. Tarn, D.; Ashley, C. E.; Xue, M.; Carnes, E. C.; Zink, J. I.; Brinker, C. J. Mesoporous Silica Nanoparticle Nanocarriers: Biofunctionality and Biocompatibility Acc. Chem. Res. 2013, 46, 792-801
12. Rosenholm, J. M.; Meinander, A.; Peuhu, E.; Niemi, R.; Eriksson, J. E.; Sahlgren, C.; Linden, M. Targeting of Porous Hybrid Silica Nanoparticles to Cancer Cells ACS Nano 2009, 3, 197-206
13. Ferris, D. P.; Lu, J.; Gothard, C.; Yanes, R.; Thomas, C. R.; Olsen, J. C.; Stoddart, J. F.; Tamanoi, F.; Zink, J. I. Synthesis of Biomolecule-Modified Mesoporous Silica Nanoparticles for Targeted Hydrophobic Drug Delivery to Cancer Cells Small 2011, 7, 1816-1826
14. Zhu, C. L.; Song, X. Y.; Zhou, W. H.; Yang, H. H.; Wen, Y. H.; Wang, X. R. An Efficient Cell-Targeting and Intracellular Controlled-Release Drug Delivery System Based on MSN-PEM-Aptamer Conjugates J. Mater. Chem. 2009, 19, 7765-7770
15. Tsai, C. P.; Chen, C. Y.; Hung, Y.; Chang, F. H.; Mou, C. Y. Monoclonal Antibody-Functionalized Mesoporous Silica Nanoparticles (MSN) for Selective Targeting Breast Cancer Cells J. Mater. Chem. 2009, 19, 5737-5743
16. Lu, J.; Liong, M.; Li, Z.; Zink, J. I.; Tamanoi, F. Biocompatibility, Biodistribution, and Drug-Delivery Efficiency of Mesoporous Silica Nanoparticles for Cancer Therapy in Animals Small 2010, 6, 1794-1805
17. Lu, J.; Li, Z.; Zink, J. I.; Tamanoi, F. In Vivo Tumor Suppression Efficacy of Mesoporous Silica Nanoparticles-Based Drug-Delivery System: Enhanced Efficacy by Folate Modification Nanomedicine 2012, 8, 212-220
18. Davis, M. E.; Chen, Z. G.; Shin, D. M. Nanoparticle Therapeutics: an Emerging Treatment Modality for Cancer Nat. Rev. Drug Discovery 2008, 7, 771-782
19. Hong, H.; Zhang, Y.; Sun, J.; Cai, W. Molecular Imaging and Therapy of Cancer with Radiolabeled Nanoparticles Nano Today 2009, 4, 399-413
20. Kim, J.; Kim, H. S.; Lee, N.; Kim, T.; Kim, H.; Yu, T.; Song, I. C.; Moon, W. K.; Hyeon, T. Multifunctional Uniform Nanoparticles Composed of a Magnetite Nanocrystal Core and a Mesoporous Silica Shell for Magnetic Resonance and Fluorescence Imaging and for Drug Delivery Angew. Chem., Int. Ed. 2008, 47, 8438-8441
21. Lee, J. E.; Lee, N.; Kim, H.; Kim, J.; Choi, S. H.; Kim, J. H.; Kim, T.; Song, I. C.; Park, S. P.; Moon, W. K. et al. Uniform Mesoporous Dye-Doped Silica Nanoparticles Decorated with Multiple Magnetite Nanocrystals for Simultaneous Enhanced Magnetic Resonance Imaging, Fluorescence Imaging, and Drug Delivery J. Am. Chem. Soc. 2010, 132, 552-557
22. Meng, H.; Xue, M.; Xia, T.; Ji, Z.; Tarn, D. Y.; Zink, J. I.; Nel, A. E. Use of Size and a Copolymer Design Feature to Improve the Biodistribution and the Enhanced Permeability and Retention Effect of Doxorubicin-Loaded Mesoporous Silica Nanoparticles in a Murine Xenograft Tumor Model ACS Nano 2011, 5, 4131-4144
23. Shi, S.; Yang, K.; Hong, H.; Valdovinos, H. F.; Nayak, T. R.; Zhang, Y.; Theuer, C. P.; Barnhart, T. E.; Liu, Z.; Cai, W. Tumor Vasculature Targeting and Imaging in Living Mice with Reduced Graphene Oxide Biomaterials 2013, 34, 3002-3009
24. Hong, H.; Yang, K.; Zhang, Y.; Engle, J. W.; Feng, L.; Yang, Y.; Nayak, T. R.; Goel, S.; Bean, J.; Theuer, C. P. et al. In Vivo Targeting and Imaging of Tumor Vasculature with Radiolabeled, Antibody-Conjugated Nanographene ACS Nano 2012, 6, 2361-2370
25. Xiao, Y.; Hong, H.; Javadi, A.; Engle, J. W.; Xu, W.; Yang, Y.; Zhang, Y.; Barnhart, T. E.; Cai, W.; Gong, S. Multifunctional Unimolecular Micelles for Cancer-Targeted Drug Delivery and Positron Emission Tomography Imaging Biomaterials 2012, 33, 3071-3082
26. Bergers, G.; Benjamin, L. E. Tumorigenesis and the Angiogenic Switch Nat. Rev. Cancer 2003, 3, 401-410
27. Folkman, J. Angiogenesis in Cancer, Vascular, Rheumatoid and Other Disease Nat. Med. 1995, 1, 27-31
28. Seon, B. K.; Haba, A.; Matsuno, F.; Takahashi, N.; Tsujie, M.; She, X.; Harada, N.; Uneda, S.; Tsujie, T.; Toi, H. et al. Endoglin-Targeted Cancer Therapy Curr. Drug Delivery 2011, 8, 135-143
29. Fonsatti, E.; Nicolay, H. J.; Altomonte, M.; Covre, A.; Maio, M. Targeting Cancer Vasculature via Endoglin/CD105: a Novel Antibody-Based Diagnostic and Therapeutic Strategy in Solid Tumours Cardiovasc. Res. 2010, 86, 12-19
30. Dallas, N. A.; Samuel, S.; Xia, L.; Fan, F.; Gray, M. J.; Lim, S. J.; Ellis, L. M. Endoglin (CD105): a Marker of Tumor Vasculature and Potential Target for Therapy Clin. Cancer Res. 2008, 14, 1931-1937
31. Rosen, L. S.; Hurwitz, H. I.; Wong, M. K.; Goldman, J.; Mendelson, D. S.; Figg, W. D.; Spencer, S.; Adams, B. J.; Alvarez, D.; Seon, B. K. et al. A Phase I First-in-Human Study of TRC105 (Anti-Endoglin Antibody) in Patients with Advanced Cancer Clin. Cancer Res. 2012, 18, 4820-4829
32. 89Zr-Df-TRC105 Eur. J. Nucl. Med. Mol. Imaging 2012, 39, 138-148
33. Hong, H.; Yang, Y.; Zhang, Y.; Engle, J. W.; Barnhart, T. E.; Nickles, R. J.; Leigh, B. R.; Cai, W. Positron Emission Tomography Imaging of CD105 Expression during Tumor Angiogenesis Eur. J. Nucl. Med. Mol. Imaging 2011, 38, 1335-1343
34. 89Zr and IRDye 800CW Mol. Pharm. 2012, 9, 2339-2349
35. Pan, L.; He, Q.; Liu, J.; Chen, Y.; Ma, M.; Zhang, L.; Shi, J. Nuclear-Targeted Drug Delivery of TAT Peptide-Conjugated Monodisperse Mesoporous Silica Nanoparticles J. Am. Chem. Soc. 2012, 134, 5722-5725
36. 66Ga-Labeled Nano-Graphene Biomaterials 2012, 33, 4147-4156
37. Yuan, L.; Tang, Q.; Yang, D.; Zhang, J. Z.; Zhang, F.; Hu, J. Preparation of pH-Responsive Mesoporous Silica Nanoparticles and Their Application in Controlled Drug Delivery J. Phys. Chem. C 2011, 115, 9926-9932
38. Almeida, J. P. M.; Chen, A. L.; Foster, A.; Drezek, R. In Vivo Biodistribution of Nanoparticles Nanomedicine 2011, 6, 815-835
39. He, X.; Nie, H.; Wang, K.; Tan, W.; Wu, X.; Zhang, P. In Vivo Study of Biodistribution and Urinary Excretion of Surface-Modified Silica Nanoparticles Anal. Chem. 2008, 80, 9597-9603
40. Souris, J. S.; Lee, C. H.; Cheng, S. H.; Chen, C. T.; Yang, C. S.; Ho, J. A.; Mou, C. Y.; Lo, L. W. Surface Charge-Mediated Rapid Hepatobiliary Excretion of Mesoporous Silica Nanoparticles Biomaterials 2010, 31, 5564-5574
41. Fu, C.; Liu, T.; Li, L.; Liu, H.; Chen, D.; Tang, F. The Absorption, Distribution, Excretion and Toxicity of Mesoporous Silica Nanoparticles in Mice Following Different Exposure Routes Biomaterials 2013, 34, 2565-2575
42. Holland, J. P.; Cumming, P.; Vasdev, N. PET Radiopharmaceuticals for Probing Enzymes in the Brain Am. J. Nucl. Med. Mol. Imaging 2013, 3, 194-216
43. Nolting, D. D.; Nickels, M. L.; Guo, N.; Pham, W. Molecular Imaging Probe Development: a Chemistry Perspective Am. J. Nucl. Med. Mol. Imaging 2012, 2, 273-306
44. Kumar, R.; Roy, I.; Ohulchanskky, T. Y.; Vathy, L. A.; Bergey, E. J.; Sajjad, M.; Prasad, P. N. In Vivo Biodistribution and Clearance Studies Using Multimodal Organically Modified Silica Nanoparticles ACS Nano 2010, 4, 699-708
45. Yu, T.; Greish, K.; McGill, L. D.; Ray, A.; Ghandehari, H. Influence of Geometry, Porosity, and Surface Characteristics of Silica Nanoparticles on Acute Toxicity: Their Vasculature Effect and Tolerance Threshold ACS Nano 2012, 6, 2289-2301
46. Nichols, J. W.; Bae, Y. H. Odyssey of a Cancer Nanoparticle: from Injection Site to Site of Action Nano Today 2012, 7, 606-618
47. Liu, H.; Liu, T.; Wu, X.; Li, L.; Tan, L.; Chen, D.; Tang, F. Targeting Gold Nanoshells on Silica Nanorattles: a Drug Cocktail to Fight Breast Tumors via a Single Irradiation with Near-Infrared Laser Light Adv. Mater. 2012, 24, 755-761
48. Zhang, Y.; Hong, H.; Engle, J. W.; Yang, Y.; Barnhart, T. E.; Cai, W. Positron Emission Tomography and Near-Infrared Fluorescence Imaging of Vascular Endothelial Growth Factor with Dual-Labeled Bevacizumab Am. J. Nucl. Med. Mol. Imaging 2012, 2, 1-13
49. 64Cu-Labeled Second Generation HaloTag Ligands Am. J. Transl. Res. 2013, 5, 291-302